P07 Development of a decision-making tool to aid implementation of the national guideline on extended-interval gentamicin in neonates

AimTo implement the dosing and monitoring recommendations of the national gentamicin guideline for neonates1 and the British National Formulary (BNF) for Children.2 To assist the transition with the development of a decision-making flowchart.MethodA baseline audit (n=30) was conducted in the neonata...

Full description

Saved in:
Bibliographic Details
Published in:Archives of disease in childhood 2018-02, Vol.103 (2), p.e1-e1
Main Authors: Ruth, Hodgins, Deirdre, Gilpin, Deirdre, Schoen
Format: Article
Language:English
Subjects:
Children
Clinical decision making
Creatinine
Decision making
Dosage
Drug dosages
Education
Educational Change
Gentamicin
Guidelines
Medical errors
National Standards
Neonates
Newborn babies
Pediatrics
Renal function
Therapeutic drug monitoring
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:AimTo implement the dosing and monitoring recommendations of the national gentamicin guideline for neonates1 and the British National Formulary (BNF) for Children.2 To assist the transition with the development of a decision-making flowchart.MethodA baseline audit (n=30) was conducted in the neonatal unit (NICU) to assess compliance with the national guideline and highlight areas to target for change and improvement. A new local gentamicin guideline and a decision-making flowchart were developed and implemented. Education on the new practices was provided. A post-implementation audit (n=28) was performed to assess compliance and measure changes. The new dosage regimen involved giving a dose of 5 mg/kg every 36 hours to neonates with a postnatal age (PNA) of
ISSN:0003-9888
1468-2044
DOI:10.1136/archdischild-2017-314584.18